New gene therapy gel may prevent amputations for diabetics - KCBD NewsChannel 11 Lubbock


New gene therapy gel may prevent amputations for diabetics

By Kristin Beerman | email

Edited by Jon Bush | email 

LUBBOCK, TX (KCBD) – Over 24-million Americans have diabetes, of those approximately three-million will develop hard to heal foot ulcers.  Now there's a promising new treatment that could help heal those wounds before amputation becomes necessary.  It's an investigational product called Excellarate. It's a gene therapy gel applied directly to the wound.

"The gene therapeutic component encodes for proteins that help stimulate the wound healing process," said Scott Lipkin, D.P.M.  "The most impressive results from this study are that participants who received one treatment of Excellarate exhibited about 50-percent healing within 12-weeks. Fifty-percent is really phenomenal."

Excellarate is an investigational gel being tested for non-healing diabetic foot wounds.  Of the patients be treated with the gel, 48-percent had complete wound closure within 12-weeks after a single application of Excellarate.  For more information on Excellerate, please (click here).

©2010 KCBD NewsChannel 11.  All rights reserved.  This material may not be published, broadcast, rewritten, or redistributed.

Powered by Frankly